Doro AB

  • ISIN: SE0000215493
  • Land: .

Nachricht vom 21.03.2012 | 17:00

Bulletin from Doro AB’s Annual General Meeting 2012


Doro AB 

21.03.2012 17:00

Lund, Sweden, 2012-03-21 17:00 CET (GLOBE NEWSWIRE) -- At the Annual General Meeting of Doro AB (publ), held on 21 March 2012, it was resolved, inter alia: * to adopt the income statement and balance sheet, and the consolidated income statement and the consolidated balance sheet; * to distribute a dividend of SEK 1 per share for the financial year 2011; * to discharge from liability the members of the board of directors and the CEO for the financial year 2011; * to re-elect Bo Kastensson, Karin Moberg, Jonas Mårtensson, Jérôme Arnaud and Charlotta Falvin as members of the board of directors for the period up to and including the next annual general meeting; * to re-elect Bo Kastensson as the chairman of the board of directors; * remuneration to the board as follows: the chairman receives SEK 350,000 and other members not employed by the company receive SEK 150,000 each; * to adopt principles for the appointment of the nomination committee; * to authorize the board, for the period until the next annual general meeting, to resolve, on one or several occasions, to issue not more than 1,930,000 shares without preferential rights for the shareholders. Such new issue resolution shall include a provision that new shares shall be paid in kind; and * to adopt remuneration guidelines with the principal effect that salaries and other terms of remuneration for the group management shall be on market terms. For more information, please contact: President and CEO Jérôme Arnaud, +46 (0)46 280 50 05, or Vice President and CFO Annette Borén, +46 (0)706 30 00 09. This is information that Doro AB (publ) is required to publish in accordance with the Swedish Securities Markets Act and/or the Swedish Financial Trading Act. This information was submitted for publication on March 21, 2012 at 5 p.m CET. News Source: NASDAQ OMX 21.03.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English Company: Doro AB Sweden Phone: Fax: E-mail: Internet: ISIN: SE0000215493 WKN: End of Announcement DGAP News-Service

Event im Fokus

62. m:access Analystenkonferenz

Datum: 13.10.2016
Zeit: 09:30 - 17:00 Uhr
Ort: Börse München
Karolinenplatz 6
80333 München

GBC im Fokus

Ergomed: Stabile Cashflows im Servicegeschäft, hohes Upside im Biotech-Portfolio

Die 1997 gegründete Ergomed plc (GB00BN7ZCY67) bietet für die pharmazeutische Industrie Dienstleistungen im Bereich der Entwicklung von pharmazeutischen Wirkstoffen an. Ergomed führt dabei klinische Entwicklungsprogramme für über 100 Kunden durch. Zusätzlich baut Ergomed ein Portfolio an Co-Entwicklungs-Partnerschaften mit Pharma- und Biotech-Unternehmen auf. Im Erfolgsfall ergibt sich hieraus ein hohes Gewinnpotenzial. Die Bewertung der Ergomed wurde auf Basis einer Sum-of-the-parts Analyse über das Servicegeschäft und Produktportfolio erstellt. Dabei haben wir einen fairen Wert für die Ergomed von 3,22 € pro Aktie ermittelt und vergeben das Rating KAUFEN.

Aktueller Webcast

Rocket Internet SE

H1 2016 Results for Rocket Internet and Selected Portfolio Companies

22. September 2016

Aktuelle Research-Studie

Golden Dawn Minerals Inc.

Original-Research: Golden Dawn Minerals Inc. (von Rockstone Research Ltd.): -

28. September 2016